• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

FDA issues final rule on device, drug, biologic combinations

January 22, 2013 By drugdelivery

FDA logo

Federal regulators this week published a final rule governing Current Good Manufacturing Practice requirements for products made up of a combination of devices, drugs and/or biologics, categories which are usually regulated by separate FDA divisions.

The long-awaited rule is meant to provide clarification on CGMP requirements for products that include any fusion of the medical products either as packaged together or as a "single-entity" combination.

The final rule is "largely identical" to what the FDA proposed in September 2009, based off of draft guidance 1st published in 2004, which was generally met with support, according to the federal watchdog agency.

The new guidelines apply equally to existing as well as new products, despite some requests that the regulation be forward-looking only. The FDA asked makers of existing combination products to comply with the new CGMP guidelines, but promised to issue guidance to help manufacturers alter systems as need be for products already on the market.

The FDA also shielded certain manufacturers from the CGMP rules, applying the guidelines to both "specification" develops and contract manufacturers, but left out component manufacturers, even if a component will be incorporated into the final product.

Guidelines for certain combination products, such as those including parts that are separately manufactured and marketed, are straightforward, with each piece regulated under existing guidelines for its respective category.

For packages the FDA calls "single-entity and co-packaged combination products" the rules are less clear, and those combinations are the focus of the new rule.

 

Filed Under: Drug-Device Combinations

IN CASE YOU MISSED IT

  • Medtronic to invest $50M in India Diabetes center
  • Flat Medical partners with Mercury Medical on smart syringe distribution
  • Glucotrack to effect a reverse stock split
  • Medtronic unveils ‘MiniMed’ as name for soon-to-be separated Diabetes unit
  • Insulet, Marvel collab to unveil comic book hero with type 1 diabetes

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS